Toth Financial Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History

Toth Financial Advisory’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.5K	Buy	20 +19	+1,900%	+$12.9K	﹤0.01%	561
2026 Q1	$773	Buy	+1	New	+$766	﹤0.01%	831
2023 Q2	–	Sell	-8	Closed	-$6.57K	–	874
2023 Q1	$6.57K	Buy	+8	New	+$6.03K	﹤0.01%	507
2022 Q3	–	Sell	-9	Closed	-$5K	–	785
2022 Q2	$5K	Buy	9 +4	+80%	+$2.6K	﹤0.01%	519
2022 Q1	$3K	Hold	5	–	–	﹤0.01%	596
2021 Q4	$3K	Hold	5	–	–	﹤0.01%	618
2021 Q3	$3K	Hold	5	–	–	﹤0.01%	617
2021 Q2	$3K	Hold	5	–	–	﹤0.01%	562
2021 Q1	$2K	Hold	5	–	–	﹤0.01%	606
2020 Q4	$2K	Hold	5	–	–	﹤0.01%	545
2020 Q3	$3K	Hold	5	–	–	﹤0.01%	459
2020 Q2	$3K	Hold	5	–	–	﹤0.01%	448
2020 Q1	$2K	Hold	5	–	–	﹤0.01%	394
2019 Q4	$2K	Buy	+5	New	+$1.68K	﹤0.01%	431

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Toth Financial Advisory's REGN Position: Q2 2026 in Review

Toth Financial Advisory increased its Regeneron Pharmaceuticals (REGN) stake by 1,900% in Q2 2026, buying an estimated $12.9K and bringing the position to 20 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #561.

Toth Financial Advisory first reported a position in REGN in Q4 2019 and has held it in 14 quarters since. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Toth Financial Advisory held 20 shares of Regeneron Pharmaceuticals worth $12.5K as of Q2 2026.
Toth Financial Advisory bought 19 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $12.9K.
Regeneron Pharmaceuticals made up ﹤0.01% of Toth Financial Advisory's portfolio in Q2 2026, its #561 holding.
Toth Financial Advisory first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 14 quarters since.
1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.